These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38554998)

  • 1. Substance use disorder treatment carve outs in Medicaid managed care.
    Silverman AF; Westlake MA; Hinds OM; Harris SJ; Abraham AJ; Grogan CM; Andrews CM
    J Subst Use Addict Treat; 2024 Jun; 161():209357. PubMed ID: 38554998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Medicaid Managed Care Drug Carve Outs With Hepatitis C Virus Prescription Use.
    Auty SG; Shafer PR; Dusetzina SB; Griffith KN
    JAMA Health Forum; 2021 Aug; 2(8):e212285. PubMed ID: 35977199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Between Medicaid Managed Care Coverage of Substance Use Services and Treatment Utilization.
    Auty SG; Cole MB; Wallace J
    JAMA Health Forum; 2022 Aug; 3(8):e222812. PubMed ID: 36218990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coverage and Prior Authorization Policies for Medications for Opioid Use Disorder in Medicaid Managed Care.
    Abraham AJ; Andrews CM; Harris SJ; Westlake MM; Grogan CM
    JAMA Health Forum; 2022 Nov; 3(11):e224001. PubMed ID: 36331441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Mental Health Parity and Addiction Equity Act (MHPAEA) evaluation study: Did parity differentially affect substance use disorder and mental health benefits offered by behavioral healthcare carve-out and carve-in plans?
    Friedman SA; Azocar F; Xu H; Ettner SL
    Drug Alcohol Depend; 2018 Sep; 190():151-158. PubMed ID: 30032052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of behavioral health care in Medicaid managed care carve-out versus carve-in arrangements.
    Charlesworth CJ; Zhu JM; Horvitz-Lennon M; McConnell KJ
    Health Serv Res; 2021 Oct; 56(5):805-816. PubMed ID: 34312839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The economic functions of carve outs in managed care.
    Frank RG; McGuire TG
    Am J Manag Care; 1998 Jun; 4 Suppl():SP31-9. PubMed ID: 10184945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What Happens When Employers Switch from a "Carve-Out" to a "Carve-In" Model of Managed Behavioral Health?
    Ettner SL; Xu H; Azocar F
    J Ment Health Policy Econ; 2019 Sep; 22(3):85-94. PubMed ID: 31811752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Carving out" conditions from global capitation rates: protecting high-cost patients, physicians, and health plans in a managed care environment.
    Maguire AM; Powe NR; Starfield B; Andrews J; Weiner JP; Anderson GF
    Am J Manag Care; 1998 Jun; 4(6):797-806. PubMed ID: 10181066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of a statewide carve out on spending and access to substance abuse treatment in Massachusetts, 1992 to 1996.
    Shepard DS; Daley M; Ritter GA; Hodgkin D; Beinecke RH
    Health Serv Res; 2001 Dec; 36(6 Pt 2):32-44. PubMed ID: 16148959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Managing Medicaid behavioral health care: findings of a national survey in the year 2000.
    Ridgely MS; Maglione MA
    Psychiatr Serv; 2006 Jul; 57(7):1000-6. PubMed ID: 16816285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substitution in a Medicaid mental health carve-out: services and costs.
    Libby AM; Cuellar A; Snowden LR; Orton HD
    J Health Care Finance; 2002; 28(4):11-23. PubMed ID: 12148661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Commercial plans in Medicaid managed care: understanding who stays and who leaves.
    Long SK; Yemane A
    Health Aff (Millwood); 2005; 24(4):1084-94. PubMed ID: 16012149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A publicly managed Medicaid substance abuse carve-out: effects on spending and utilization.
    Hodgkin D; Shepard DS; Anthony YE; Strickler GK
    Adm Policy Ment Health; 2004 Jan; 31(3):197-217. PubMed ID: 15160784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance Metrics of Substance Use Disorder Care Among Medicaid Enrollees in New York, New York.
    Alegría M; Falgas-Bague I; Fukuda M; Zhen-Duan J; Weaver C; O'Malley I; Layton T; Wallace J; Zhang L; Markle S; Neighbors C; Lincourt P; Hussain S; Manseau M; Stein BD; Rigotti N; Wakeman S; Kane M; Evins AE; McGuire T
    JAMA Health Forum; 2022 Jul; 3(7):e221771. PubMed ID: 35977217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carve outs: definition, experience, and choice among candidate conditions.
    Blumenthal D; Buntin MB
    Am J Manag Care; 1998 Jun; 4 Suppl():SP45-57. PubMed ID: 10184946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Managed care and the quality of substance abuse treatment.
    Shepard DS; Daley M; Ritter GA; Hodgkin D; Beinecke RH
    J Ment Health Policy Econ; 2002 Dec; 5(4):163-74. PubMed ID: 14578550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Most States Allow Medicaid Managed Care Plans Discretion To Restrict Substance Use Disorder Treatment Benefits.
    Peterson LA; Andrews CM; Abraham AJ; Westlake MA; Grogan CM
    Health Aff (Millwood); 2024 Jul; 43(7):1038-1046. PubMed ID: 38950296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Mental Health Parity and Addiction Equity Act (MHPAEA) Evaluation Study: Impact on Quantitative Treatment Limits.
    Thalmayer AG; Friedman SA; Azocar F; Harwood JM; Ettner SL
    Psychiatr Serv; 2017 May; 68(5):435-442. PubMed ID: 27974003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Second-generation antipsychotic use among stimulant-using children, by organization of medicaid mental health.
    Saloner B; Matone M; Kreider AR; Budeir MS; Miller D; Huang YS; Raghavan R; French B; Rubin D
    Psychiatr Serv; 2014 Dec; 65(12):1458-64. PubMed ID: 25179737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.